Hepagene Therapeutics
Nanjing
About Hepagene Therapeutics
Hepagene Therapeutics works towards developing medicines that help patients overcome liver diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $40.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2021)
- Website: hepagene.com
- Phone: [email protected]
Industries & Categories
Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/hepagene-therapeutics-80440 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.